Previous 10 | Next 10 |
EDEN PRAIRIE, Minn., May 30, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, announced it will be presenting at the upcoming 2023 America...
EDEN PRAIRIE, Minn., May 30, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, announced that members of the management team will participa...
2023-05-14 04:25:21 ET Miromatrix Medical Inc. (MIRO) Q1 2023 Earnings Conference Call May 11, 2023 04.30 PM ET Company Participants Hannah Jeffrey - Gilmartin, Investor Relations Jeff Ross - Chief Executive Officer Jim Douglas - Chief Financial Officer Con...
2023-05-11 16:05:29 ET Miromatrix Medical press release ( NASDAQ: MIRO ): Q1 GAAP EPS of -$0.33 misses by $0.04 . Revenue of $7.98M (+17.9% Y/Y). For further details see: Miromatrix Medical GAAP EPS of -$0.33 misses by $0.04, revenue of $7.98M
EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today reported first quarter 2023 financial results and prov...
EDEN PRAIRIE, Minn., April 27, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced that the Company will report financ...
EDEN PRAIRIE, Minn., April 10, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced that CEO Jeff Ross, Ph.D will present at ...
CareDx Exclusive Provider of dd-cfDNA Testing Services for Use in Miromatrix Clinical Trials Companies at Forefront of Alternative Organ Supply Research to Address Organ Shortage BRISBANE, Calif. and EDEN PRAIRIE, Minn., April 05, 2023 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDN...
2023-03-31 21:38:08 ET Miromatrix Medical Inc. (MIRO) Q4 2022 Earnings Conference Call March 31, 2023 16:30 ET Company Participants Hannah Jeffrey - Investor Relations Jeff Ross - Chief Executive Officer Jim Douglas - Chief Financial Officer Conference Call...
2023-03-31 16:06:20 ET Miromatrix Medical press release ( NASDAQ: MIRO ): Q4 GAAP EPS of -$0.33 beats by $0.06 . Revenue of $0.93M (-88.4% Y/Y) beats by $0.93M . For further details see: Miromatrix Medical GAAP EPS of -$0.33 beats by $0.06, revenue of $0....
News, Short Squeeze, Breakout and More Instantly...
Miromatrix Medical Inc. Company Name:
MIRO Stock Symbol:
NASDAQ Market:
United Therapeutics Corporation (Nasdaq: UTHR ) and Miromatrix Medical Inc. (Nasdaq: MIRO ) announced today that United Therapeutics, through its wholly owned subsidiary Morpheus Subsidiary Inc. (“ Merger Sub ”), has successfully completed the previously announced tender...
United Therapeutics Corporation (Nasdaq: UTHR ) and Miromatrix Medical Inc. (Nasdaq: MIRO ) announced today the results of the previously announced tender offer by Morpheus Subsidiary Inc. (“ Merger Sub ”), a wholly owned subsidiary of United Therapeutics, to acquire all...
NEW YORK, NY / ACCESSWIRE / November 18, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CapStar Financial Holdings, Inc. ...